FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shimon Slavin

Research Profile

Procedures

Living Beings

Disorders

Chemicals & Drugs

Anatomy

Physiology

Graft vs Leukemia Effect

Co-author Network

Publications

TOP 3
Shoshana Morecki; Idit Sagiv Barfi; Y Shabat; O Eizik; Yael Gelfand; Elena Yacovlev; Shimon Slavin
Selective elimination of alloreactivity in vitro and in vivo while sparing other T-cell-mediated immune responses.
Ilan Volovitz; Meir Azulay; Irun R Cohen; Ofir Goldberger; Arthur Machlenkin; Yotvat Marmor; Felix Mor; Zvi Ram; Shimon Slavin; Lea Eisenbach
Split immunity: immune inhibition of rat gliomas by subcutaneous exposure to unmodified live tumor cells.
Gregory Elkin; Olga Gurevitch; Sofia Khitrin; Tatyana B Prigozhina; Shimon Slavin; Igor B Resnick
Visualization of immune response kinetics in full allogeneic chimeras.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shimon Slavin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Shoshana Morecki; Idit Sagiv Barfi; Y Shabat; O Eizik; Yael Gelfand; Elena Yacovlev; Shimon Slavin
Selective elimination of alloreactivity in vitro and in vivo while sparing other T-cell-mediated immune responses.
Bone marrow transplantation 2012;47(6):838-45.
2011: Ilan Volovitz; Meir Azulay; Irun R Cohen; Ofir Goldberger; Arthur Machlenkin; Yotvat Marmor; Felix Mor; Zvi Ram; Shimon Slavin; Lea Eisenbach
Split immunity: immune inhibition of rat gliomas by subcutaneous exposure to unmodified live tumor cells.
Journal of immunology (Baltimore, Md. : 1950) 2011;187(10):5452-62.
2011: Gregory Elkin; Olga Gurevitch; Sofia Khitrin; Tatyana B Prigozhina; Shimon Slavin; Igor B Resnick
Visualization of immune response kinetics in full allogeneic chimeras.
American journal of blood research 2011;1(2):110-8.
2010: Dimitrios Karussis; Clementine Karageorgiou; Adi Vaknin-Dembinsky; Basan Gowda-Kurkalli; John Moshe Gomori; Ibrahim Kassis; Jeff W M Bulte; Panayiota Petrou; Tamir Ben-Hur; Oded Abramsky; Shimon Slavin
Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.
Archives of neurology 2010;67(10):1187-94.
2010: Panagiotis Tsirigotis; Michael Y Shapira; Reuven Or; Menachem Bitan; Simcha Samuel; Benjamin Gesundheit; Aliza Ackerstein; Ali Abdul-Hai; Shimon Slavin; Igor B Resnick
The number of infused CD34+ cells does not influence the incidence of GVHD or the outcome of allogeneic PBSC transplantation, using reduced-intensity conditioning and antithymocyte globulin.
Bone marrow transplantation 2010;45(7):1189-96.
2010: Menachem Bitan; Lola Weiss; Israel Reibstein; Michael Zeira; Yakov Fellig; Shimon Slavin; Eyal Zcharia; Arnon Nagler; Israel Vlodavsky
Heparanase upregulates Th2 cytokines, ameliorating experimental autoimmune encephalitis.
Molecular immunology 2010;47(10):1890-8.
2010: Jing Dong Qin; Lola Weiss; Shimon Slavin; Shimon Gatt; Arie Dagan
Synthetic, non-natural analogs of ceramide elevate cellular ceramide, inducing apoptotic death to prostate cancer cells and eradicating tumors in mice.
Cancer investigation 2010;28(5):535-43.
2010: Menachem Bitan; Lola Weiss; Michael Zeira; Eyal Zcharia; Shimon Slavin; Arnon Nagler; Israel Vlodavsky
Heparanase promotes engraftment and prevents graft versus host disease in stem cell transplantation.
PloS one 2010;5(4):e10135.
2009: Shoshana Morecki; Shimon Slavin
Immunoregulation of GVHD by triggering the innate immune system with CpG.
Expert review of hematology 2009;2(4):443-53.
2009: Meirav Kedmi; Igor B Resnick; Liliane Dray; Memet Aker; Simcha Samuel; Benjamin Gesundheit; Shimon Slavin; Reuven Or; Michael Y Shapira
A retrospective review of the outcome after second or subsequent allogeneic transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(4):483-9.
2009: Shoshana Morecki; Elena Yacovlev; Yael Gelfand; Yehudit Shabat; Shimon Slavin
Induction of graft-versus-leukemia (GVL) effect without graft-versus-host disease (GVHD) by pretransplant donor treatment with immunomodulators.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(4):406-15.
2009: M Har-Noy; Michael Zeira; Lola Weiss; E Fingerut; Reuven Or; Shimon Slavin
Allogeneic CD3/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia/lymphoma.
Leukemia research 2009;33(4):525-38.
2009: Michael Y Shapira; Ali Abdul-Hai; Igor B Resnick; Menachem Bitan; Panagiotis Tsirigotis; Memet Aker; Benjamin Gesundheit; Shimon Slavin; Reuven Or
Alefacept treatment for refractory chronic extensive GVHD.
Bone marrow transplantation 2009;43(4):339-43.
2009: Panagiotis Tsirigotis; Igor B Resnick; Reuven Or; Sharon Elad; Irina Zilberman; Luba Yoffe; Alexander Levovic; Svetlana Miron; Benjamin Gesundheit; Shimon Slavin; Michael Y Shapira
Post-hematopoietic stem cell transplantion immune-mediated cytopenias.
Immunotherapy 2009;1(1):39-47.
2009: Olga Gurevitch; Shimon Slavin; Igor B Resnick; Sofia Khitrin; A Feldman
Mesenchymal progenitor cells in red and yellow bone marrow.
Folia biologica 2009;55(1):27-34.
2008: Tatyana B Prigozhina; Gregory Elkin; Sofia Khitrin; Shimon Slavin
Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
Experimental hematology 2008;36(12):1750-9.
2008: M Har-Noy; Michael Zeira; Lola Weiss; Shimon Slavin
Completely mismatched allogeneic CD3/CD28 cross-linked Th1 memory cells elicit anti-leukemia effects in unconditioned hosts without GVHD toxicity.
Leukemia research 2008;32(12):1903-13.
2008: Tatyana B Prigozhina; Sofia Khitrin; Gregory Elkin; Osnat Eizik; Shoshana Morecki; Shimon Slavin
Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
Experimental hematology 2008;36(10):1370-6.
2008: Shoshana Morecki; Yael Gelfand; Elena Yacovlev; Osnat Eizik; Yehudit Shabat; Shimon Slavin
CpG-induced myeloid CD11b+Gr-1+ cells efficiently suppress T cell-mediated immunoreactivity and graft-versus-host disease in a murine model of allogeneic cell therapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(9):973-84.
2008: Shoshana Morecki; Horst Lindhofer; Elena Yacovlev; Yael Gelfand; Peter Ruf; Shimon Slavin
Induction of long-lasting antitumor immunity by concomitant cell therapy with allogeneic lymphocytes and trifunctional bispecific antibody.
Experimental hematology 2008;36(8):997-1003.
2008: Menachem Bitan; Lola Weiss; Michael Zeira; Shoshana Reich; Orit Pappo; Israel Vlodavsky; Shimon Slavin
Heparanase prevents the development of type 1 diabetes in non-obese diabetic mice by regulating T-cell activation and cytokines production.
Diabetes/metabolism research and reviews 2008;24(5):413-21.
2008: Igor B Resnick; Panagiotis Tsirigotis; Michael Y Shapira; Memet Aker; Menachem Bitan; Simcha Samuel; Ali Abdul-Hai; Aliza Ackerstein; Reuven Or; Shimon Slavin
ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(4):409-17.
2008: Lola Weiss; Ana Maria Botero-Anug; Carla Hand; Shimon Slavin; David Naor
CD44 gene vaccination for insulin-dependent diabetes mellitus in non-obese diabetic mice.
The Israel Medical Association journal : IMAJ 2008;10(1):20-5.
2008: M Har-Noy; Shimon Slavin
The anti-tumor effect of allogeneic bone marrow/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement?
Medical hypotheses 2008;70(6):1186-92.
2008: Menachem Bitan; Reuven Or; Michael Y Shapira; Igor B Resnick; Benjamin Gesundheit; Aliza Ackerstein; Simcha Samuel; Sharon Elad; Shimon Slavin
Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemia.
Bone marrow transplantation 2008;41(1):69-78.
2008: Lola Weiss; Michael Zeira; Shoshana Reich; Shimon Slavin; Itamar Raz; Urij Rampampam; Ruth Gallily
Cannabidiol arrests onset of autoimmune diabetes in NOD mice.
Neuropharmacology 2008;54(1):244-9.
2007: Panagiotis Tsirigotis; Tamar Sella; Michael Y Shapira; Menachem Bitan; Allan I Bloom; D Kiselgoff; M Levin; Diana Libster; A Abdul Hai; Benjamin Gesundheit; Reuven Or; Shimon Slavin; Igor B Resnick
Peliosis hepatis following treatment with androgen-steroids in patients with bone marrow failure syndromes.
Haematologica 2007;92(11):e106-10.
2007: Igor B Resnick; Memet Aker; Panagiotis Tsirigotis; Michael Y Shapira; Ali Abdul-Hai; Menachem Bitan; Benjamin Gesundheit; Avraham Amar; Aliza Ackerstein; Simcha Samuel; Shimon Slavin; Reuven Or
Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen.
Bone marrow transplantation 2007;40(10):957-64.
2007: Ali Abdul-Hai; Lola Weiss; David Ergas; Igor B Resnick; Shimon Slavin; Michael Y Shapira
The effect of high-dose thiotepa, alone or in combination with other chemotherapeutic agents, on a murine B-cell leukemia model simulating autologous stem cell transplantation.
Bone marrow transplantation 2007;40(9):891-6.
2007: Ali Abdul-Hai; Lola Weiss; Arie Ben-Yehuda; David Ergas; Michael Y Shapira; Shimon Slavin
Interleukin-7 induced facilitation of immunological reconstitution of sublethally irradiated mice following treatment with alloreactive spleen cells in a murine model of B-cell leukemia/lymphoma (BCL1).
Bone marrow transplantation 2007;40(9):881-9.
2007: Johnny Amer; Lola Weiss; Shoshana Reich; Michael Y Shapira; Shimon Slavin; Eitan Fibach
The oxidative status of blood cells in a murine model of graft-versus-host disease.
Annals of hematology 2007;86(10):753-8.
2007: Michael Y Shapira; Panagiotis Tsirigotis; Igor B Resnick; Reuven Or; Ali Abdul-Hai; Shimon Slavin
Allogeneic hematopoietic stem cell transplantation in the elderly.
Critical reviews in oncology/hematology 2007;64(1):49-63.
2007: David Naor; Shlomo Nedvetzki; Marita Walmsley; Avner Yayon; Eva A Turley; Ilan Golan; Dan Caspi; Lora Eshkar Sebban; Yehiel Zick; tali garin; Dimitrios Karussis; Nathalie Assayag-Asherie; Itamar Raz; Lola Weiss; Shimon Slavin; Itshak Golan
CD44 involvement in autoimmune inflammations: the lesson to be learned from CD44-targeting by antibody or from knockout mice.
Annals of the New York Academy of Sciences 2007;1110():233-47.
2007: Shoshana Morecki; Elena Yacovlev; Yael Gelfand; Osnat Eizik; Shimon Slavin
Pretransplant treatment of donors with immunomodulators to control graft-versus-host disease (GVHD) in transplant recipients.
Experimental hematology 2007;35(5):748-56.
2007: Tatyana B Prigozhina; Gregory Elkin; Shimon Slavin
Deletion of donor-reactive cells as a new conditioning regimen for allogeneic bone marrow transplantation.
Transplantation proceedings 2007;39(3):678-84.
2007: Lola Weiss; Shoshana Reich; Michael Zeira; Reuven Or; Igor B Resnick; Shimon Slavin; Michael Y Shapira
N-acetylcysteine mildly inhibits the graft-vs.-leukemia effect but not the lymphokine activated cells (LAK) activity.
Transplant immunology 2007;17(3):198-202.
2007: Michael Y Shapira; Ali Abdul Hai; Panagiotis Tsirigotis; Igor B Resnick; Reuven Or; Shimon Slavin
Hematopoietic stem cell therapy for malignant diseases.
Annals of medicine 2007;39(6):465-73.
2007: Olga Gurevitch; Shimon Slavin; Anatol G Feldman
Conversion of red bone marrow into yellow - Cause and mechanisms.
Medical hypotheses 2007;69(3):531-6.
2007: Olga Gurevitch; Sofia Khitrin; Andrei Valitov; Shimon Slavin
Osteoporosis of hematologic etiology.
Experimental hematology 2007;35(1):128-36.
2006: Reuven Or; E Hadar; Menachem Bitan; Igor B Resnick; Memet Aker; Aliza Ackerstein; Simcha Samuel; Panagiotis Tsirigotis; Benjamin Gesundheit; Shimon Slavin; Michael Y Shapira
Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(12):1295-301.
2006: Ali Abdul-Hai; Arie Ben-Yehuda; Haya Galsky; Shimon Slavin; Reuven Or
Interleukin 2 regulation following semi-allogeneic bone marrow transplantation in mice.
Cancer immunology, immunotherapy : CII 2006;55(11):1330-6.
2006: M Miodosky; Ali Abdul-Hai; Panagiotis Tsirigotis; Reuven Or; Menachem Bitan; Igor B Resnick; Benjamin Gesundheit; Irina Zilberman; L Ioffe; Alexander Leubovic; Shimon Slavin; Michael Y Shapira
Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate.
Bone marrow transplantation 2006;38(7):507-11.
2006: E Hirshfeld; Lola Weiss; Judith Kasir; Michael Zeira; Shimon Slavin; Michael Y Shapira
Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
Bone marrow transplantation 2006;38(5):359-64.
2006: Menachem Bitan; Reuven Or; Michael Y Shapira; Memet Aker; Igor B Resnick; Aliza Ackerstein; Simcha Samuel; Sharon Elad; Shimon Slavin
Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(7):712-8.
2006: Panagiotis Tsirigotis; Reuven OrMenachem Bitan; Igor B Resnick; Simcha Samuel; Aliza Ackerstein; Sharon Eladì; Benjamin Gesundheit; Irina Zilberman; Svetlana Miron; Alexander Leubovic; Shimon Slavin; Michael Y Shapira
A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients.
Haematologica 2006;91(6):852-5.
2006: David J Gross; Gabriel Munter; Menachem Bitan; Tali Siegal; Alberto Gabizon; Ronny Weitzen; Ofer Merimsky; Aliza Ackerstein; Asher Salmon; Avishai Sella; Shimon Slavin
The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R.
Endocrine-related cancer 2006;13(2):535-40.
2006: Igor B Resnick; Memet Aker; Michael Y Shapira; Panagiotis Tsirigotis; Menachem Bitan; Ali Abdul-Hai; Simcha Samuel; Aliza Ackerstein; Benjamin Gesundheit; Irina Zilberman; Svetlana Miron; Luba Yoffe; Alex Lvovich; Shimon Slavin; Reuven Or
Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen.
British journal of haematology 2006;133(6):649-54.
2006: Michael Y Shapira; Igor B Resnick; Panagiotis Tsirigotis; Shimon Slavin
Biological response modifiers as adjuncts to stem cell transplantation.
Expert opinion on biological therapy 2006;6(5):467-83.
2006: Ali Abdul-Hai; Lola Weiss; Shimon Slavin; Reuven Or
Improved survival following induction of GVHD following lipopolysaccharide immunization.
Experimental hematology 2006;34(4):549-53.
2006: Lola Weiss; Michael Zeira; Shoshana Reich; M Har-Noy; Urij Rampampam; Shimon Slavin; Ruth Gallily
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.
Autoimmunity 2006;39(2):143-51.
2006: Dimitrios Karussis; Savvas Grigoriadis; Eleni Polyzoidou; Nikolaos Grigoriadis; Shimon Slavin; Oded Abramsky
Neuroprotection in multiple sclerosis.
Clinical neurology and neurosurgery 2006;108(3):250-4.
2006: Shoshana Morecki; Horst Lindhofer; Elena Yacovlev; Yael Gelfand; Shimon Slavin
Use of trifunctional bispecific antibodies to prevent graft versus host disease induced by allogeneic lymphocytes.
Blood 2006;107(4):1564-9.
2006: Olga Gurevitch; Shimon Slavin
The hematological etiology of osteoporosis.
Medical hypotheses 2006;67(4):729-35.
2005: Igor B Resnick; Ali Abdul-Hai; Michael Y Shapira; Menachem Bitan; Eli Hershkovitz; Arie Schwartz; Miriam Ben-Harush; Reuven Or; Shimon Slavin; Joseph Kapelushnik
Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen.
Clinical transplantation 2005;19(6):840-7.
2005: Michael Y Shapira; Igor B Resnick; Menachem Bitan; Aliza Ackerstein; Panagiotis Tsirigotis; Benjamin Gesundheit; Irina Zilberman; Svetlana Miron; Alexander Leubovic; Shimon Slavin; Reuven Or
Rapid response to alefacept given to patients with steroid resistant or steroid dependent acute graft-versus-host disease: a preliminary report.
Bone marrow transplantation 2005;36(12):1097-101.
2005: Iris Yang; Iris Yung; Lola Weiss; Ali Abdul-Hai; Judith Kasir; Shoshana Reich; Shimon Slavin
Induction of early post-transplant graft-versus-leukemia effects using intentionally mismatched donor lymphocytes and elimination of alloantigen-primed donor lymphocytes for prevention of graft-versus-host disease.
Cancer research 2005;65(21):9735-40.
2005: Menachem Bitan; Reuven Or; Michael Y Shapira; Igor B Resnick; Aliza Ackerstein; Simcha Samuel; Sharon Elad; Shimon Slavin
Successful engraftment following allogeneic stem cell transplantation in very high-risk patients with busulfan as a single agent.
Haematologica 2005;90(8):1089-95.
2005: Igor B Resnick; Michael Y Shapira; Shimon Slavin
Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
Transplant immunology 2005;14(3-4):207-19.
2005: Menachem Bitan; Michael Y Shapira; Igor B Resnick; Irina Zilberman; Svetlana Miron; Simcha Samuel; Aliza Ackerstein; Sharon Elad; Shoshana Israel; Avraham Amar; Eitan Fibach; Reuven Or; Shimon Slavin
Successful transplantation of haploidentically mismatched peripheral blood stem cells using CD133+-purified stem cells.
Experimental hematology 2005;33(6):713-8.
2005: D De Santis; Amal Bishara; Campbell S Witt; Arnon Nagler; Chaim Brautbar; Shimon Slavin; Frank T Christiansen
Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants.
Tissue antigens 2005;65(6):519-28.
2005: Menachem Bitan; Reuven Or; Michael Y Shapira; Aliza Ackerstein; Simcha Samuel; Shimon Slavin
Nonmyeloablative stem cell transplantation using lymphoablative rather than myeloablative conditioning in the prefludarabine era by ATG and limiting doses of cyclophosphamide.
Bone marrow transplantation 2005;35(10):953-8.
2005: Michael Y Shapira; Ester Hirshfeld; Lola Weiss; Michael Zeira; Judith Kasir; Reuven Or; Igor B Resnick; Shimon Slavin
Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model.
Cancer immunology, immunotherapy : CII 2005;54(4):383-8.
2005: Ali Abdul-Hai; Rami Hershkoviz; Lola Weiss; Ofer Lider; Shimon Slavin
Effect of Linomide on adhesion molecules, TNF-alpha, nitrogen oxide, and cell adhesion.
International immunopharmacology 2005;5(2):231-9.
2005: Shimon Slavin
Allogeneic cell-mediated immunotherapy at the stage of minimal residual disease following high-dose chemotherapy supported by autologous stem cell transplantation.
Acta haematologica 2005;114(4):214-20.
2004: Igor B Resnick; John Moshe Gomori; David Kiselgoff; Alexander Lossos; Irina Zilberman; Svetlana Miron; Menachem Bitan; Reuven Or; Shimon Slavin; Michael Y Shapira
Spinal epidural lipomatosis following haploidentical allogeneic bone marrow transplantation for non-Hodgkin lymphoma.
Clinical transplantation 2004;18(6):762-5.
2004: Reuven Or; Memet Aker; Michael Y Shapira; Igor B Resnick; Menachem Bitan; Simcha Samuel; Shimon Slavin
Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products.
Springer seminars in immunopathology 2004;26(1-2):133-42.
2004: Tatyana B Prigozhina; Gregory Elkin; Sofia Khitrin; Shimon Slavin
Depletion of donor-reactive cells as a new concept for improvement of mismatched bone marrow engraftment using reduced-intensity conditioning.
Experimental hematology 2004;32(11):1110-7.
2004: Tatyana B Prigozhina; Gregory Elkin; Olga Gurevitch; Shoshana Morecki; Elena Yakovlev; Sofia Khitrin; Shimon Slavin
Depletion of alloantigen-primed lymphocytes overcomes resistance to allogeneic bone marrow in mildly conditioned recipients.
Blood cells, molecules & diseases 2004;33(3):238-47.
2004: Tatyana B Prigozhina; Shimon Slavin
Transplantation of hematopoietic stem cells for induction of unresponsiveness to organ allografts.
Springer seminars in immunopathology 2004;26(1-2):169-85.
2004: Shimon Slavin
Reduced intensity versus truly nonmyeloablative conditioning for stem-cell transplant recipients.
Transplantation 2004;78(7):964-5.
2004: Menachem Bitan; Reuven Or; Michael Y Shapira; Nurith Mador; Igor B Resnick; Niveen Saleh; Klaus M Weinberger; Simcha Samuel; Esther Schechter; Shimon Slavin; Dana G Wolf
Early-onset Guillain-Barré syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(7):1076-8.
2004: Dimitrios Karussis; Shimon Slavin
Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures.
Journal of the neurological sciences 2004;223(1):59-64.
2004: Soumya Panigrahi; Shoshana Morecki; Elena Yacovlev; Yael Gelfand; Judith Kassir; Shimon Slavin
A novel approach for prevention of lethal GVHD by selective elimination of alloreactive donor lymphocytes prior to stem cell transplantation.
Experimental hematology 2004;32(8):756-64.
2004: Shimon Slavin
Smarter rather than stronger treatment of haematological malignancies and non-malignant indications for stem-cell transplantation.
Lancet 2004;364(9429):122-4.
2004: Shoshana Morecki; Soumya Panigrahi; Galina Pizov; Elena Yacovlev; Yael Gelfand; Osnat Eizik; Shimon Slavin
Effect of KRN7000 on induced graft-vs-host disease.
Experimental hematology 2004;32(7):630-7.
2004: Michael Y Shapira; Igor B Resnick; Menachem Bitan; Aliza Ackerstein; Simcha Samuel; Sharon Elad; Svetlana Miron; Irina Zilberman; Shimon Slavin; Reuven Or
Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients.
Bone marrow transplantation 2004;34(2):155-9.
2004: Gregory Elkin; Tatyana B Prigozhina; Shimon Slavin
Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation.
Experimental hematology 2004;32(6):579-84.
2004: Lola Weiss; Shoshana Reich; Ofer Mandelboim; Shimon Slavin
Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy.
Bone marrow transplantation 2004;33(11):1137-41.
2004: Lola Weiss; Reuven Or; Shimon Slavin; Elizabeth Naparstek; Shoshana Reich; Ali Abdul-Hai
Immunotherapy of murine leukemia following non-myeloablative conditioning with naïve or G-CSF mobilized blood or bone marrow stem cells.
Cancer immunology, immunotherapy : CII 2004;53(4):358-62.
2004: Allan I Bloom; Michael Y Shapira; Reuven Or; Talia Sasson; Igor B Resnick; Irina Zilberman; Anthony Verstandig; Memet Aker; Shimon Slavin; Mordechai Muszkat
Intrahepatic arterial administration of low-dose methotrexate in patients with severe hepatic graft-versus-host disease: an open-label, uncontrolled trial.
Clinical therapeutics 2004;26(3):407-14.
2004: Jonathan Kipnis; Hila Avidan; Yifat Markovich; Tal Mizrahi; Ehud Hauben; Tatyana B Prigozhina; Shimon Slavin; Michal Schwartz
Low-dose gamma-irradiation promotes survival of injured neurons in the central nervous system via homeostasis-driven proliferation of T cells.
The European journal of neuroscience 2004;19(5):1191-8.
2004: Amal Bishara; D De Santis; C C Witt; Chaim Brautbar; Frank T Christiansen; R Or; Arnon Nagler; Shimon Slavin
The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
Tissue antigens 2004;63(3):204-11.
2004: Shimon Slavin; Shoshana Morecki; Lola Weiss; Michael Y Shapira; Igor B Resnick; Reuven Or
Nonmyeloablative stem cell transplantation: reduced-intensity conditioning for cancer immunotherapy--from bench to patient bedside.
Seminars in oncology 2004;31(1):4-21.
2004: Shimon Slavin
Reduced-intensity conditioning or nonmyeloablative stem cell transplantation: introduction, rationale, and historic background.
Seminars in oncology 2004;31(1):1-3.
2004: Shoshana Morecki; Elena Yacovlev; Yael Gelfand; Anna Vilensky; Shimon Slavin
Allogeneic versus syngeneic killer splenocytes as effector cells for the induction of graft-versus-tumor effect.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(1):40-8.
2003: Menachem Bitan; Igor B Resnick; Reuven Or; Ariel Rokach; Uri Laxer; Aliza Ackerstein; Sharon Elad; Shimon Slavin; Michael Y Shapira
Rhinolalia as a presenting sign of pneumomediastinum complicating post peripheral blood stem cell transplantation bronchiolitis obliterans.
American journal of hematology 2003;74(3):182-6.
2003: Shimon Slavin
Graft-versus-host disease, the graft-versus-leukemia effect, and mixed chimerism following nonmyeloablative stem cell transplantation.
International journal of hematology 2003;78(3):195-207.
2003: David J Gross; Israel Reibstein; Lola Weiss; Shimon Slavin; Hagit Dafni; Michal Neeman; Mark Pines; Arnon Nagler
Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(10 Pt 1):3788-93.
2003: Michael Y Shapira; Reuven Or; Igor B Resnick; Menachem Bitan; Aliza Ackerstein; Simcha Samuel; Sharon Elad; Irina Zilberman; Svetlana Miron; Shimon Slavin
A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation.
Bone marrow transplantation 2003;32(6):557-61.
2003: Y H Ji; Lola Weiss; Michael Zeira; Ali Abdul-Hai; Shoshana Reich; Lucia Schuger; Shimon Slavin
Allogeneic cell-mediated immunotherapy of leukemia with immune donor lymphocytes to upregulate antitumor effects and downregulate antihost responses.
Bone marrow transplantation 2003;32(5):495-504.
2003: Shimon Slavin; Shoshana Morecki; Lola Weiss; Reuven Or
Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man.
Critical reviews in oncology/hematology 2003;46(2):139-63.
2003: Reuven Or; Michael Y Shapira; Igor B Resnick; Avraham Amar; Aliza Ackerstein; Simcha Samuel; Memet Aker; Elizabeth Naparstek; Arnon Nagler; Shimon Slavin
Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase.
Blood 2003;101(2):441-5.
2003: Deborah Patinkin; Adel Hidmi; Lola Weiss; Shimon Slavin; Jehoshua Katzhendler
The effect of pegylated antisense acetylcholinesterase on hematopoiesis.
Oligonucleotides 2003;13(4):207-16.
2003: Olga Gurevitch; Basan Gowda S Kurkalli; Tatyana B Prigozhina; Judith Kasir; Anna Gaft; Shimon Slavin
Reconstruction of cartilage, bone, and hematopoietic microenvironment with demineralized bone matrix and bone marrow cells.
Stem cells (Dayton, Ohio) 2003;21(5):588-97.
2003: Soumya Panigrahi; Mayukh Das; Dalia Stagler; Shlomi Konstantini; Moshe Gmori; Shimon Slavin; Arnon Nagler
Development of secondary anaplastic oligoastrocytoma after matched unrelated bone marrow transplantation in a child with acute myeloid leukemia.
Acta haematologica 2003;109(4):196-8.
2003: Tatyana B Prigozhina; Olga Gurevitch; Gregory Elkin; Shoshana Morecki; Elena Yakovlev; Shimon Slavin
CD40 ligand-specific antibodies synergize with cyclophosphamide to promote long-term transplantation tolerance across MHC barriers but inhibit graft-vs-leukemia effects of transplanted cells.
Experimental hematology 2003;31(1):81-8.
2002: Shimon Slavin
Non-myeloablative stem cell transplantation for induction of host-versus-graft tolerance for adoptive immunotherapy of malignant and nonmalignant diseases and towards transplantation of organ allografts.
Transplantation proceedings 2002;34(8):3371-3.
2002: Lola Weiss; Ali Abdul-Hai; Yoel Shufaro; Shoshana Reich; Shimon Slavin
Linomide administration following bone marrow transplantation in mice.
Cancer immunology, immunotherapy : CII 2002;51(11-12):596-602.
2002: Michael Y Shapira; Allan I Bloom; Reuven Or; Talia Sasson; Arnon Nagler; Igor B Resnick; Memet Aker; Irina Zilberman; Shimon Slavin; Anthony Verstanding
Intra-arterial catheter directed therapy for severe graft-versus-host disease.
British journal of haematology 2002;119(3):760-4.
2002: Shimon Slavin; Memet Aker; Michael Y Shapira; Soumya Panigrahi; Cividalli Gabriel; Reuven Or
Non-myeloablative stem cell transplantation for the treatment of cancer and life-threatening non-malignant disorders; past accomplishments and future goals.
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2002;27(2):159-66.
2002: Shimon Slavin
Maternal-fetal relationship, natural chimerism and bilateral transplantation tolerance as the basis for non-myeloablative stem cell transplantation.
International journal of hematology 2002;76 Suppl 1():172-5.
2002: Olga Gurevich; Akiva Vexler; Gerard Marx; Tatyana B Prigozhina; Lilia Levdansky; Shimon Slavin; Irina Shimeliovich; Raphael Gorodetsky
Fibrin microbeads for isolating and growing bone marrow-derived progenitor cells capable of forming bone tissue.
Tissue engineering 2002;8(4):661-72.
2002: Lola Weiss; Vivian Barak; Michael Zeira; Ali Abdul-Hai; Israel Raibstein; Shoshana Reich; Esther Hirschfeld; David Gross; Shimon Slavin
Cytokine production in Linomide-treated nod mice and the potential role of a Th (1)/Th(2) shift on autoimmune and anti-inflammatory processes.
Cytokine 2002;19(2):85-93.
2002: Gregory Elkin; TB Prighozina; Olga Gurevitch; Shimon Slavin
Nonmyeloablative bone marrow transplantation based on deletion of host-anti-donor alloreactive cells prevents autoimmune insulitis and diabetes in nonobese diabetic mice.
Transplantation proceedings 2002;34(4):1303-6.
2002: Shimon Slavin; Shoshana Morecki; Lola Weiss; Reuven Or
Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation.
Journal of hematotherapy & stem cell research 2002;11(2):265-76.
2002: Shimon Slavin; Arnon Nagler; Michael Y Shapira; Memet Aker; Cividalli Gabriel; Reuven Or
Treatment of leukemia by alloreactive lymphocytes and nonmyeloablative stem cell transplantation.
Journal of clinical immunology 2002;22(2):64-9.
2002: Soumya Panigrahi; Elena Yacovlev; Yael Gelfand; Lucia Schuger; Shimon Slavin; Shoshana Morecki
Intraportal and systemic allogeneic cell therapy in a murine model of hepatic metastatic breast cancer.
Cytokines, cellular & molecular therapy 2002;7(3):99-106.
2002: Shimon Slavin
Donor lymphocyte infusions for hematopoietic malignancy.
Cancer chemotherapy and biological response modifiers 2002;20():291-9.
2002: Tatyana B Prigozhina; Olga Gurevitch; Shoshana Morecki; Elena Yakovlev; Gregory Elkin; Shimon Slavin
Nonmyeloablative allogeneic bone marrow transplantation as immunotherapy for hematologic malignancies and metastatic solid tumors in preclinical models.
Experimental hematology 2002;30(1):89-96.
2001: Shimon Slavin; Aliza Ackerstein; Shoshana Morecki; Yael Gelfand; G Cividalli
Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes.
Bone marrow transplantation 2001;28(8):795-8.
2001: Shimon Slavin
Immunotherapy of cancer with alloreactive lymphocytes.
The lancet oncology 2001;2(8):491-8.
2001: Shimon Slavin; Reuven Or; Memet Aker; Michael Y Shapira; Soumya Panigrahi; A Symeonidis; G Cividalli; Arnon Nagler
Nonmyeloablative stem cell transplantation for the treatment of cancer and life-threatening nonmalignant disorders: past accomplishments and future goals.
Cancer chemotherapy and pharmacology 2001;48 Suppl 1():S79-84.
2001: Shoshana Morecki; Yael Gelfand; Arnon Nagler; Reuven Or; Elizabeth Naparstek; Gabor Varadi; Dan Engelhard; A Akerstein; Shimon Slavin
Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen.
Bone marrow transplantation 2001;28(3):243-9.
2001: Shimon Slavin; Arnon Nagler; M Shapira; Soumya Panigrahi; Simcha Samuel; A Or
Non-myeloablative allogeneic stem cell transplantation focusing on immunotherapy of life-threatening malignant and non-malignant diseases.
Critical reviews in oncology/hematology 2001;39(1-2):25-9.
2001: Shimon Slavin; Arnon Nagler; Memet Aker; Michael Y Shapira; G Cividalli; Reuven Or
Non-myeloablative stem cell transplantation and donor lymphocyte infusion for the treatment of cancer and life-threatening non-malignant disorders.
Reviews in clinical and experimental hematology 2001;5(2):135-46.
2001: David J Gross; Lola Weiss; Israel Reibstein; Gunnar Hedlund; Eva Dahlén; M J Rapoport; Shimon Slavin
The immunomodulator Linomide: role in treatment and prevention of autoimmune diabetes mellitus.
International immunopharmacology 2001;1(6):1131-9.
2001: Soumya Panigrahi; Arnon Nagler; Reuven Or; Dana G Wolf; Shimon Slavin; Michael Y Shapira
Indolent aspergillus arthritis complicating fludarabine-based non-myeloablative stem cell transplantation.
Bone marrow transplantation 2001;27(6):659-61.
2001: Arnon Nagler; Memet Aker; Reuven Or; Elizabeth Naparstek; Gabor Varadi; Chaim Brautbar; Shimon Slavin
Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation.
Experimental hematology 2001;29(3):362-70.
2001: Shoshana Morecki; Elena Yacovlev; Yael Gelfand; I Uzi; Shimon Slavin
Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2001;24(2):114-21.
2000: Arnon Nagler; Aliza Ackerstein; Reuven Or; Elizabeth Naparstek; Shimon Slavin
Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantation.
Experimental hematology 2000;28(11):1225-31.
2000: Shimon Slavin
New strategies for bone marrow transplantation.
Current opinion in immunology 2000;12(5):542-51.
2000: Yaron Ilan; Arnon Nagler; Evelyne Zeira; R Adler; Shimon Slavin; Daniel Shouval
Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients.
Bone marrow transplantation 2000;26(6):633-8.
2000: Arnon Nagler; Reuven Or; Elizabeth Naparstek; Gabor Varadi; Shimon Slavin
Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation.
Experimental hematology 2000;28(9):1096-104.
2000: Shimon Slavin; Arnon Nagler; Gabor Varadi; Reuven Or
Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis.
Experimental hematology 2000;28(7):853-7.
2000: Shoshana Morecki; Shimon Slavin
Toward amplification of a graft-versus-leukemia effect while minimizing graft-versus-host disease.
Journal of hematotherapy & stem cell research 2000;9(3):355-66.
2000: Shimon Slavin; Reuven Or; TB Prighozina; Olga Gurevitch; Memet Aker; S Panighari; M Shapira; Arnon Nagler
Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man.
Bone marrow transplantation 2000;25 Suppl 2():S54-7.
2000: Arnon Nagler; Shimon Slavin; Gabor Varadi; Elizabeth Naparstek; Simcha Samuel; Reuven Or
Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
Bone marrow transplantation 2000;25(10):1021-8.
2000: Shoshana Morecki; Elena Yacovlev; Yael Gelfand; V Trembovler; E Shohami; Shimon Slavin
Induction of antitumor immunity by indomethacin.
Cancer immunology, immunotherapy : CII 2000;48(11):613-20.
2000: Lola Weiss; Shimon Slavin; S Reich; P Cohen; S Shuster; R Stern; Ella Kaganovsky; E Okon; A M Rubinstein; D Naor
Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(1):285-90.
1999: Olga Gurevitch; Tatyana B Prigozhina; T Pugatsch; Shimon Slavin
Transplantation of allogeneic or xenogeneic bone marrow within the donor stromal microenvironment.
Transplantation 1999;68(9):1362-8.
1999: David J Gross; Israel Reibstein; Lola Weiss; Shimon Slavin; Ilan Stein; Michal Neeman; Rinat Abramovitch; Laura E Benjamin
The antiangiogenic agent linomide inhibits the growth rate of von Hippel-Lindau paraganglioma xenografts to mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(11):3669-75.
1999: F Rosales; Elizabeth Naparstek; Gabor Varadi; Reuven Or; Shimon Slavin; Arnon Nagler
The role of thiotepa in allogeneic stem cell transplantation in patients with leukemia.
Leukemia research 1999;23(10):947-52.
1999: Tatyana B Prigozhina; Olga Gurevitch; Shimon Slavin
Nonmyeloablative conditioning to induce bilateral tolerance after allogeneic bone marrow transplantation in mice.
Experimental hematology 1999;27(10):1503-10.
1999: Lola Weiss; Shoshana Reich; Shimon Slavin
Allogeneic cell therapy in murine B-cell leukemia (BCL1): 2. The role of non-activated and rIL-2-activated CD4+ and CD8+ T cells in immunotherapy for leukemia.
Cytokines, cellular & molecular therapy 1999;5(3):153-8.
1999: Lola Weiss; Shoshana Reich; Shimon Slavin
Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.
Cytokines, cellular & molecular therapy 1999;5(3):145-52.
1999: Arnon Nagler; Aliza Ackerstein; Joseph Kapelushnik; Reuven Or; Elizabeth Naparstek; Shimon Slavin
Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease.
Bone marrow transplantation 1999;24(3):339-42.
1999: Elizabeth Naparstek; M Delukina; Reuven Or; Arnon Nagler; Joseph Kapelushnik; Gabor Varadi; N Strauss; G Cividalli; Memet Aker; Chaim Brautbar; H Waldmann; G Hale; Shimon Slavin
Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
Experimental hematology 1999;27(7):1210-8.
1999: M Mumcuoglu; Shimon Slavin
Enhancement of hematopoietic reconstitution with recombinant cytokines: effect of rhIL-6 in combination with rhGM-CSF and rhIL-3 on unmodified or T cell-depleted bone marrow.
Journal of hematotherapy 1999;8(3):247-53.
1999: Lola Weiss; Shimon Slavin
Prevention and treatment of graft-versus-host disease by down-regulation of anti-host reactivity with veto cells of host origin.
Bone marrow transplantation 1999;23(11):1139-43.
1999: Gabor Varadi; Reuven Or; Joseph Kapelushnik; Elizabeth Naparstek; Arnon Nagler; Chaim Brautbar; Avraham Amar; M Kirschbaum; Simcha Samuel; Shimon Slavin; Tali Siegal
Graft-versus-lymphoma effect after allogeneic peripheral blood stem cell transplantation for primary central nervous system lymphoma.
Leukemia & lymphoma 1999;34(1-2):185-90.
1999: Memet Aker; Gabor Varadi; Shimon Slavin; Arnon Nagler
Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemia.
Journal of pediatric hematology/oncology 1999;21(3):237-9.
1999: F Rosales; Nilli Peylan-Ramu; G Cividalli; Gabor Varadi; Reuven Or; Elizabeth Naparstek; Shimon Slavin; Arnon Nagler
The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases.
Bone marrow transplantation 1999;23(9):861-5.
1999: Arnon Nagler; Shoshana Morecki; Shimon Slavin
The use of soybean agglutinin (SBA) for bone marrow (BM) purging and hematopoietic progenitor cell enrichment in clinical bone-marrow transplantation.
Molecular biotechnology 1999;11(2):181-94.
1999: Arie Ben-Yehuda; E Wirtheim; Ali Abdul-Hai; Reuven Or; Shimon Slavin; S Babaey; Gideon Friedman
Activation of the recombination activating gene 1 (RAG-1) transcript in bone marrow of senescent C57BL/6 mice by recombinant interleukin-7.
The journals of gerontology. Series A, Biological sciences and medical sciences 1999;54(4):B143-8.
1999: U Vourka-Karussis; Aliza Ackerstein; T Pugatsch; Shimon Slavin
Allogeneic cell-mediated immunotherapy for eradication of minimal residual disease: comparison of T-cell and IL-2 activated killer (LAK) cell-mediated adoptive immunotherapy in murine models.
Experimental hematology 1999;27(3):461-9.
1999: Shimon Slavin; TB Prighozina; Olga Gurevitch; J Zhu; D Gross; I Rabstein; Lola Weiss
New approaches for control of anti-self reactivity in type 1 diabetes mellitus and transplantation of pancreatic islets.
Journal of molecular medicine (Berlin, Germany) 1999;77(1):223-5.
1998: Shimon Slavin; Olga Gurevitch; TB Prighozina
Induction of bilateral transplantation tolerance to cellular and perfused allografts and xenografts with donor hematopoietic cells.
Annals of the New York Academy of Sciences 1998;862():37-44.
1998: Shimon Slavin; Olga Gurevitch; J Zhu; TB Prighozina
Deletion of donor-reactive cells followed by stem cell transplantation in recipients treated with total lymphoid-irradiation as a means for induction of transplantation tolerance to organ allografts and xenografts.
Transplantation proceedings 1998;30(8):4021-2.
1998: Reuven Or; Aliza Ackerstein; Arnon Nagler; Avraham Amar; Elizabeth Naparstek; Gabor Varadi; Joseph Kapelushnik; Simcha Samuel; T Pugatsch; Chaim Brautbar; Shimon Slavin
Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1998;21(6):447-53.
1998: Arnon Nagler; R Finlander; Reuven Or; Elizabeth Naparstek; Gabor Varadi; Shimon Slavin
The role of thiotepa in autologous bone marrow transplantation for acute leukemia.
Leukemia research 1998;22(11):991-5.
1998: Shoshana Morecki; Elena Yacovlev; A Diab; Shimon Slavin
Allogeneic cell therapy for a murine mammary carcinoma.
Cancer research 1998;58(17):3891-5.
1998: Shoshana Morecki; Arnon Nagler; Zichria Zakay-Rones; M Schlesinger; A Lubina-Salomon; T Pugatsch; Y Moshel; Shimon Slavin
Tumorigenicity and immunogenicity in a murine model of B-cell leukemia/lymphoma (BCL1).
Leukemia research 1998;22(9):831-5.
1998: Arnon Nagler; Reba Condiotti; C Nabet; Elizabeth Naparstek; Reuven Or; Simcha Samuel; Shimon Slavin
Selective CD4+ T-cell depletion does not prevent graft-versus-host disease.
Transplantation 1998;66(1):138-41.
1998: Amal Bishara; Memet Aker; Avraham Amar; Chaim Brautbar; M Schlesinger; R Rabinowitz; Shimon Slavin; M Baniyash
Enhanced lymphoid cell recovery after bone marrow transplantation: correlation with the presence of costimulatory antibodies in serum.
Experimental hematology 1998;26(7):580-7.
1998: Shoshana Morecki; A Lubina-Salomon; Shimon Slavin; Arnon Nagler
Cytokine gene transduction into non-immunogeneic murine tumor cells.
Cytokines, cellular & molecular therapy 1998;4(2):87-94.
1998: David J Gross; Lola Weiss; Israel Reibstein; J van den Brand; H Okamoto; A Clark; Shimon Slavin
Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide-induced immunoregulation combined with Reg protein treatment.
Endocrinology 1998;139(5):2369-74.
1998: Joseph Kapelushnik; Memet Aker; T Pugatsch; Simcha Samuel; Shimon Slavin
Bone marrow transplantation from a cadaveric donor.
Bone marrow transplantation 1998;21(8):857-8.
1998: Shoshana Morecki; L Yacovlev; Shimon Slavin
Effect of indomethacin on tumorigenicity and immunity induction in a murine model of mammary carcinoma.
International journal of cancer. Journal international du cancer 1998;75(6):894-9.
1998: Reuven Or; Aliza Ackerstein; Arnon Nagler; Joseph Kapelushnik; Elizabeth Naparstek; Simcha Samuel; Avraham Amar; C Bruatbar; Shimon Slavin
Allogeneic cell-mediated immunotherapy for breast cancer after autologous stem cell transplantation: a clinical pilot study.
Cytokines, cellular & molecular therapy 1998;4(1):1-6.
1998: Memet Aker; Joseph Kapelushnik; T Pugatsch; Elizabeth Naparstek; S Ben-Neria; O Yehuda; Avraham Amar; Arnon Nagler; Shimon Slavin; Reuven Or
Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for beta-thalassemia major.
Journal of pediatric hematology/oncology 1998;20(2):145-8.
1998: Shimon Slavin; Arnon Nagler; Elizabeth Naparstek; Y Kapelushnik; Memet Aker; G Cividalli; Gabor Varadi; M Kirschbaum; Aliza Ackerstein; Simcha Samuel; Avraham Amar; Chaim Brautbar; Ofira Ben-Tal; Amiram Eldor; Reuven Or
Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.
Blood 1998;91(3):756-63.
1998: Arnon Nagler; Shoshana Morecki; Shimon Slavin
The Use of Soybean Agglutinin (SBA) for Bone Marrow (BM) Purging and Hematopoietic Progenitor Cell Enrichment in Clinical Bone Marrow Transplantation.
Methods in molecular medicine 1998;9():329-50.
1998: Arnon Nagler; Aliza Ackerstein; M Ben-Shahar; R Or; Elizabeth Naparstek; Rami Ben-Yosef; Shimon Slavin
Continuous interleukin-2 infusion combined with cyclophosphamide- based combination chemotherapy in the treatment of hemato-oncological malignancies. Results of a phase I-II study.
Acta haematologica 1998;100(2):63-8.
1998: Shimon Slavin; Arnon Nagler
Immunotherapy in conjunction with autologous and allogeneic blood or marrow transplantation in lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9 Suppl 1():S31-9.
1997: Joseph Kapelushnik; Reuven Or; Shimon Slavin; Arnon Nagler
A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia.
Bone marrow transplantation 1997;20(12):1109-10.
1997: Shimon Slavin; Arnon Nagler
Cytokine-mediated immunotherapy following autologous bone marrow transplantation in lymphoma and evidence of interleukin-2-induced immunomodulation in allogeneic transplants.
The cancer journal from Scientific American 1997;3 Suppl 1():S59-67.
1997: Tatyana B Prigozhina; Olga Gurevitch; J Zhu; Shimon Slavin
Induction of mixed hematopoietic chimerism and specific transplantation tolerance to allogeneic and xenogeneic grafts by selective elimination of donor-reactive host cells following nonmyeloablative conditioning.
Transplantation proceedings 1997;29(6):2644-6.
1997: Rami Ben-Yosef; Reuven Or; Elizabeth Naparstek; Joseph Kapelushnik; S Samuels; Shimon Slavin; Arnon Nagler
Should soybean agglutinin purging be performed in breast cancer patients undergoing autologous stem cell transplantation? A retrospective analysis of 48 patients.
American journal of clinical oncology 1997;20(4):419-23.
1997: Shimon Slavin; Lola Weiss; TB Prighozina; Olga Gurevitch; J Zhu; I Rabstein; D Gross
New approaches for control of anti-self-reactivity in type 1 diabetes and transplantation of pancreatic islets.
Transplantation proceedings 1997;29(4):1929-31.
1997: Arnon Nagler; Aliza Ackerstein; Reuven Or; Elizabeth Naparstek; Shimon Slavin
Immunotherapy with recombinant human interleukin-2 and recombinant interferon-alpha in lymphoma patients postautologous marrow or stem cell transplantation.
Blood 1997;89(11):3951-9.
1997: Orit Shapira-Nahor; Hadar Marcus; H Segall; Ido Lubin; Shimon Slavin; Amos Panet; Yair Reisner
Human T cells recovered from human/Balb radiation chimeras are hypersensitive to human immunodeficiency virus type 1 infection.
Journal of virology 1997;71(6):4495-501.
1997: Tatyana B Prigozhina; Olga Gurevitch; J Zhu; Shimon Slavin
Permanent and specific transplantation tolerance induced by a nonmyeloablative treatment to a wide variety of allogeneic tissues: I. Induction of tolerance by a short course of total lymphoid irradiation and selective elimination of the donor-specific host lymphocytes.
Transplantation 1997;63(10):1394-9.
1997: Shoshana Morecki; Yael Gelfand; S Levi; Arnon Nagler; Reba Condiotti; C Nabet; Aliza Ackerstein; Shimon Slavin
Activated long-term peripheral blood cultures as preparation for adoptive alloreactive cell therapy in cancer patients.
Journal of hematotherapy 1997;6(2):115-24.
1997: Shoshana Morecki; Y Moshel; Y Gelfend; T Pugatsch; Shimon Slavin
Induction of graft vs. tumor effect in a murine model of mammary adenocarcinoma.
International journal of cancer. Journal international du cancer 1997;71(1):59-63.
1997: Ali Abdul-Hai; Arie Ben-Yehuda; Lola Weiss; Gideon Friedman; Zichria Zakay-Rones; Shimon Slavin; Reuven Or
Interleukin-7-enhanced cytotoxic T lymphocyte activity after viral infection in marrow transplanted mice.
Bone marrow transplantation 1997;19(6):539-43.
1997: Shoshana Morecki; C Nabet; P Falk; Masha Fridkis-Hareli; Israel Pecht; J J Mond; Shimon Slavin
The effect of linomide, an immunoregulator in experimental autoimmune diseases, on humoral antibody responses in mice.
Autoimmunity 1997;25(4):223-32.
1996: Olga Gurevitch; Shimon Slavin; A Muhlrad; Arie Shteyer; D Gazit; M Chorev; M Vidson; Malka Namdar-Attar; E Berger; I Bleiberg; I Bab
Osteogenic growth peptide increases blood and bone marrow cellularity and enhances engraftment of bone marrow transplants in mice.
Blood 1996;88(12):4719-24.
1996: Joseph Kapelushnik; Arnon Nagler; Reuven Or; Elizabeth Naparstek; Aliza Ackerstein; Simcha Samuel; Shoshana Morecki; C Nabet; Shimon Slavin
Activated allogeneic cell therapy (allo-ACT) for relapsed chronic myelogenous leukemia (CML) refractory to buffy coat transfusions post-allogeneic bone marrow transplantation.
Bone marrow transplantation 1996;18(6):1153-6.
1996: Shimon Slavin
Immunoregulation rather than immunosuppression for prevention and treatment of autoimmune disorders.
Transplantation proceedings 1996;28(6):3021-2.
1996: S Singhal; U Vourka-Karussis; J Mehta; Shimon Slavin; Lola Weiss
Failure of cyclosporine to induce graft-vs-host disease or graft-vs-leukemia after syngeneic bone marrow transplantation in mice.
Leukemia research 1996;20(11-12):941-6.
1996: Shimon Slavin; Lola Weiss; W Xia; David J Gross
Successful treatment of diabetes in NOD mice with advanced disease by islet isografts following immunoregulation with Linomide (quinoline-3-carboxamide).
Cell transplantation 1996;5(6):627-30.
1996: M Mumcuoglu; Zichria Zakay-Rones; Lola Weiss; Shimon Slavin
Enhancement of primary and secondary responses to sheep red blood cells and influenza virus in BALB/c mice by recombinant human interleukin-2.
Experimental hematology 1996;24(13):1516-20.
1996: Arnon Nagler; Chaim Brautbar; Shimon Slavin; Amal Bishara
Bone marrow transplantation using unrelated and family related donors: the impact of HLA-C disparity.
Bone marrow transplantation 1996;18(5):891-7.
1996: Lola Weiss; Samir Nusair; Shoshana Reich; H Sidi; Shimon Slavin
Induction of graft versus leukemia effects by cell-mediated lymphokine-activated immunotherapy after syngeneic bone marrow transplantation in murine B cell leukemia.
Cancer immunology, immunotherapy : CII 1996;43(2):103-8.
1996: G Arad; M Katzenellenbogen; R Levy; Shimon Slavin; Raymond Kaempfer
Linomide, an immunomodulator that inhibits Th1 cytokine gene expression.
International immunology 1996;8(10):1603-7.
1996: Ali Abdul-Hai; Reuven Or; Shimon Slavin; Gideon Friedman; Lola Weiss; D Matsa; Arie Ben-Yehuda
Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice.
Experimental hematology 1996;24(12):1416-22.
1996: Amos Toren; D Novick; Aliza Ackerstein; Reuven Or; Shimon Slavin; Arnon Nagler
Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation.
Bone marrow transplantation 1996;18(4):721-4.
1996: R Or; Joseph Kapelushnik; Elizabeth Naparstek; Arnon Nagler; Dvora Filon; Ariella Oppenheim; Avraham Amar; Memet Aker; Simcha Samuel; Shimon Slavin
Second transplantation using allogeneic peripheral blood stem cells in a beta-thalassaemia major patient featuring stable mixed chimaerism.
British journal of haematology 1996;94(2):285-7.
1996: Amos Toren; D Novick; Reuven Or; Aliza Ackerstein; Shimon Slavin; Arnon Nagler
Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation.
Transplantation 1996;62(1):138-42.
1996: Lola Weiss; Shoshana Reich; Shimon Slavin
Effect of deoxyspergualin on graft-versus-host disease and graft- versus-leukemia in mice.
Bone marrow transplantation 1996;17(5):789-92.
1996: Shimon Slavin; Elizabeth Naparstek; Arnon Nagler; Y Kapelushnik; Aliza Ackerstein; Reuven Or
Allogeneic cell therapy: the treatment of choice for all hematologic malignancies relapsing post BMT.
Blood 1996;87(9):4011-3.
1996: Reuven Or; Arnon Nagler; O Shpilberg; Sharon Elad; Elizabeth Naparstek; Joseph Kapelushnik; Y Cass; S Gillis; A Chetrit; Shimon Slavin; Amiram Eldor
Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients.
Transplantation 1996;61(7):1067-71.
1996: Shimon Slavin; Elizabeth Naparstek; Arnon Nagler; Aliza Ackerstein; Simcha Samuel; Joseph Kapelushnik; Chaim Brautbar; Reuven Or
Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation.
Blood 1996;87(6):2195-204.
1996: Dan Engelhard; H Elishoov; N Strauss; Elizabeth Naparstek; Arnon Nagler; Albert Simhon; D Raveh; Shimon Slavin; Reuven Or
Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter. A 5-year prospective study.
Transplantation 1996;61(3):430-4.
1996: T Pugatsch; Ariella Oppenheim; Shimon Slavin
Improved single-step PCR assay for sex identification post-allogeneic sex-mismatched BMT.
Bone marrow transplantation 1996;17(2):273-5.
1996: Gavriel Chaushu; Stella Chaushu; Shimon Slavin; Reuven Or; Adi A Garfunkel; Eitan Yefenof
Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
Bone marrow transplantation 1996;17(2):237-41.
1996: R Condiotti; Shimon Slavin; A Nagler
ASTA-Z 7557 impairs human natural killer (NK) cell activity.
Leukemia research 1996;20(2):169-74.
1996: Amos Toren; Reuven Or; Joseph Kapelushnik; G Chividalli; M Aku; Shimon Slavin; Arnon Nagler
Normalization of serum lactic dehydrogenase in beta-thalassemia patients following bone marrow transplantation.
American journal of hematology 1996;51(2):166-7.
1996: Shoshana Morecki; T Pugatsch; S Levi; Y Moshel; Shimon Slavin
Tumor-cell vaccination induces tumor dormancy in a murine model of B-cell leukemia/lymphoma (BCL1).
International journal of cancer. Journal international du cancer 1996;65(2):204-8.
1996: Elizabeth Naparstek; Arnon Nagler; Reuven Or; Joseph Kapelushnik; Shimon Slavin
Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
Clinical transplants 1996;():281-90.
1996: Reba Condiotti; Shimon Slavin; Vivian Barak; Arnon Nagler
The novel immunomodulator, Linomide, stimulates interleukin-2-induced human natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors.
Leukemia research 1996;20(1):57-63.
1995: Gabor Varadi; Reuven Or; D Rund; H Orbach; Shimon Slavin; Arnon Nagler
Severe migratory polyarthritis following in vivo CAMPATH-1G.
Bone marrow transplantation 1995;16(6):843-5.
1995: Shimon Slavin; Elizabeth Naparstek; Arnon Nagler; Aliza Ackerstein; Joseph Kapelushnik; Reuven Or
Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Experimental hematology 1995;23(14):1553-62.
1995: Shimon Slavin; D Gross; Lola Weiss
Prevention and treatment of type I diabetes in NOD mice by linomide.
Transplantation proceedings 1995;27(6):3240.
1995: Arnon Nagler; Reuven Or; Benjamin Nisman; Inna Kalickman; Shimon Slavin; Vivian Barak
Elevated inflammatory cytokine levels in bone marrow graft rejection.
Transplantation 1995;60(9):943-8.
1995: Arnon Nagler; Amiram Eldor; Elizabeth Naparstek; M Mumcuoglu; Shimon Slavin; varda deutsch
Ex vivo expansion of megakaryocyte precursors by preincubation of marrow allografts with interleukin-3 and granulocyte-macrophage colony-stimulating factor in vitro.
Experimental hematology 1995;23(12):1268-74.
1995: Joseph Kapelushnik; Reuven Or; Dvora Filon; Arnon Nagler; G Cividalli; Memet Aker; Elizabeth Naparstek; Shimon Slavin; Ariella Oppenheim
Analysis of beta-globin mutations shows stable mixed chimerism in patients with thalassemia after bone marrow transplantation.
Blood 1995;86(8):3241-6.
1995: Arnon Nagler; varda deutsch; Gabor Varadi; M Pick; Amiram Eldor; Shimon Slavin
Recombinant human interleukin-6 accelerates in-vitro megakaryocytopoiesis and platelet recovery post autologous peripheral blood stem cell transplantation.
Leukemia & lymphoma 1995;19(3-4):343-9.
1995: Shoshana Morecki; S Levi; Y Puyesky; Shimon Slavin
Induction of tumor immunity by intact irradiated leukemic B cells (BCL1) bearing a tumor-associated cell-surface idiotype and the costimulatory B7 molecule.
Cancer immunology, immunotherapy : CII 1995;41(4):236-42.
1995: Amos Toren; Aliza Ackerstein; Shimon Slavin; Arnon Nagler
Role of interleukin-2 in human hematological malignancies.
Medical oncology (Northwood, London, England) 1995;12(3):177-86.
1995: Lola Weiss; Shoshana Reich; Shimon Slavin
The role of antibodies to IL-2 receptor and Asialo GM1 on graft-versus-leukemia effects induced by bone marrow allografts in murine B cell leukemia.
Bone marrow transplantation 1995;16(3):457-61.
1995: M Delukina; Y Kapelushnik; Reuven Or; Elizabeth Naparstek; Shimon Slavin; Arnon Nagler
Successful matched unrelated transplantation from a donor with idiopathic thrombocytopenic purpura (ITP).
Medical oncology (Northwood, London, England) 1995;12(2):125-7.
1995: Arnon Nagler; V Segal; Shimon Slavin; Francesca Levi-Schaffer
Ketotifen therapy in chronic graft-versus-host disease (cGVHD): effect on mast cells and fibroblasts.
Clinical and experimental immunology 1995;100(3):529-35.
1995: Dimitrios Karussis; U Vourka-Karussis; D Lehmann; Oded Abramsky; Avraham Ben-Nun; Shimon Slavin
Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT).
Clinical and experimental immunology 1995;100(1):111-7.
1995: U Vourka-Karussis; Dimitrios Karussis; Aliza Ackerstein; Shimon Slavin
Enhancement of GVL effect with rhIL-2 following BMT in a murine model for acute myeloid leukemia in SJL/J mice.
Experimental hematology 1995;23(3):196-201.
1995: Arnon Nagler; Yaron Ilan; R Adler; Reuven Or; Elizabeth Naparstek; Daniel Shouval; Shimon Slavin
Successful immunization of autologous bone marrow transplantation recipients against hepatitis B virus by active vaccination.
Bone marrow transplantation 1995;15(3):475-8.
1995: Gavriel Chaushu; S Itzkovitz-Chaushu; Eitan Yefenof; Shimon Slavin; Reuven Or; Adi A Garfunkel
A longitudinal follow-up of salivary secretion in bone marrow transplant patients.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 1995;79(2):164-9.
1995: Dimitrios Karussis; D Lehmann; Shimon Slavin; T Kalland; U Vourka-Karussis; Rachel Mizrachi-Koll; Haim Ovadia; Oded Abramsky
Immunomodulation of autoimmunity by linomide.
Israel journal of medical sciences 1995;31(1):38-41.
1995: varda deutsch; T A Olson; Arnon Nagler; Shimon Slavin; R F Levine; Amiram Eldor
The response of cord blood megakaryocyte progenitors to IL-3, IL-6 and aplastic canine serum varies with gestational age.
British journal of haematology 1995;89(1):8-16.
1995: Ali Abdul-Hai; H Lorberboum-Gliski; A Mechushtan; Lola Weiss; Shimon Slavin; Reuven Or
Involvement of interleukin-2 in immunologic reconstitution following bone marrow transplantation in mice.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1995;15(1):95-101.
1994: David J Gross; H Sidi; Lola Weiss; T Kalland; E Rosenmann; Shimon Slavin
Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug.
Diabetologia 1994;37(12):1195-201.
1994: Stella Chaushu; Gavriel Chaushu; Adi A Garfunkel; Shimon Slavin; Reuven Or; Eitan Yefenof
Salivary immunoglobulins in recipients of bone marrow grafts. II. Transient secretion of donor-derived salivary IgA following transplantation of T cell-depleted bone marrow.
Bone marrow transplantation 1994;14(6):925-8.
1994: Stella Chaushu; Gavriel Chaushu; Adi A Garfunkel; Shimon Slavin; Reuven Or; Eitan Yefenof
Salivary immunoglobulins in recipients of bone marrow grafts. I. A longitudinal follow-up.
Bone marrow transplantation 1994;14(6):871-6.
1994: Lola Weiss; Ido Lubin; I Factorowich; Z Lapidot; Shoshana Reich; Yair Reisner; Shimon Slavin
Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(6):2562-7.
1994: A Amiel; S Yarkoni; Shimon Slavin; R Or; Haya Lorberboum-Galski; Moshe D Fejgin; Arnon Nagler
Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridization.
Cancer genetics and cytogenetics 1994;76(1):59-64.
1994: Yaron Ilan; Arnon Nagler; Daniel Shouval; Aliza Ackerstein; Reuven Or; Joseph Kapelushnik; R Adler; Shimon Slavin
Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors.
Clinical and experimental immunology 1994;97(2):299-302.
1994: Lola Weiss; Shimon Slavin
Effect of total lymphoid irradiation on natural killer cells and cytotoxic and primed T lymphocytes.
Israel journal of medical sciences 1994;30(4):253-9.
1994: Arnon Nagler; Shimon Slavin; S Yarkoni; Moshe D Fejgin; A Amiel
Detection of minimal residual disease after sex-mismatch bone marrow transplantation in chronic myelogenous leukemia by fluorescence in situ hybridization.
Cancer genetics and cytogenetics 1994;73(2):130-3.
1994: T Givon; M Revel; Shimon Slavin
Potential use of interleukin-6 in bone marrow transplantation: effects of recombinant human interleukin-6 after syngeneic and semiallogeneic bone marrow transplantation in mice.
Blood 1994;83(6):1690-7.
1994: Reuven Or; J Mehta; Joseph Kapelushnik; Memet Aker; Elizabeth Naparstek; Arnon Nagler; G Cividalli; Shimon Slavin
Total lymphoid irradiation, anti-lymphocyte globulin and Campath 1-G for immunosuppression prior to bone marrow transplantation for aplastic anemia after repeated graft rejection.
Bone marrow transplantation 1994;13(1):97-9.
1994: Lola Weiss; G Slavin; Shoshana Reich; H Sidi; Shimon Slavin
Successful purging of murine plasmacytoma by mafosfamide (ASTA-Z).
Bone marrow transplantation 1994;13(1):27-30.
1994: Arnon Nagler; Aliza Ackerstein; Vivian Barak; Shimon Slavin
Treatment of chronic myelogenous leukemia with recombinant human interleukin-2 and interferon-alpha 2a.
Journal of hematotherapy 1994;3(1):75-82.
1993: Shimon Slavin; H Sidi; Lola Weiss; E Rosenman; T Kalland; D Gross
Linomide, a new treatment for autoimmune diseases: the potential in type 1 diabetes.
Diabetes/metabolism reviews 1993;9(4):311-5.
1993: P Cohen; U Vourka-Karussis; Lola Weiss; Shimon Slavin
Spontaneous and IL-2-induced anti-leukemic and anti-host effects against tumor- and host-specific alloantigens.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(9):4803-10.
1993: Dimitrios Karussis; D Lehmann; Shimon Slavin; U Vourka-Karussis; Rachel Mizrachi-Koll; Haim Ovadia; Avraham Ben-Nun; T Kalland; Oded Abramsky
Inhibition of acute, experimental autoimmune encephalomyelitis by the synthetic immunomodulator linomide.
Annals of neurology 1993;34(5):654-60.
1993: T Pugatsch; Lola Weiss; Shimon Slavin
Minimal residual disease in murine B-cell leukemia (BCL1) detected by PCR.
Leukemia research 1993;17(11):999-1002.
1993: varda deutsch; Arnon Nagler; Shimon Slavin; Reba Condiotti; R F Levine; Amiram Eldor
Effect of bone marrow T lymphocytes treated with CAMPATH 1G on megakaryocyte colony formation.
Experimental hematology 1993;21(11):1427-35.
1993: P E Drakos; Arnon Nagler; Reuven Or; Elizabeth Naparstek; Joseph Kapelushnik; Dan Engelhard; Galia Rahav; D Ne'emean; Shimon Slavin
Invasive fungal sinusitis in patients undergoing bone marrow transplantation.
Bone marrow transplantation 1993;12(3):203-8.
1993: Elizabeth Naparstek; Shimon Slavin; Lola Weiss; H Sidi; M Ohana; Shoshana Reich; I Vlodavsky; I R Cohen; Y Naparstek
Low-dose heparin inhibits acute graft versus host disease in mice.
Bone marrow transplantation 1993;12(3):185-9.
1993: E Loewenthal; Lola Weiss; Simcha Samuel; Reuven Or; Shimon Slavin
Optimization of conditioning therapy for leukemia prior to BMT. I. Optimal synergism between cyclophosphamide and total body irradiation for eradication of murine B cell leukemia (BCL1).
Bone marrow transplantation 1993;12(2):109-13.
1993: Lola Weiss; S Stern; Shoshana Reich; Shimon Slavin
Effect of recombinant human manganese superoxide dismutase on radiosensitivity of murine B cell leukemia (BCL1) cells.
Leukemia & lymphoma 1993;10(6):477-81.
1993: Amal Bishara; Eli Kedar; Benny Leshem; Shimon Slavin; I Cohen; Chaim Brautbar
A 2-day MLR procedure for marrow donor selection for allogeneic bone marrow transplantation.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1993;20(4):289-92.
1993: Yaron Ilan; Arnon Nagler; R Adler; Elizabeth Naparstek; Reuven Or; Shimon Slavin; Chaim Brautbar; Daniel Shouval
Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation.
Hepatology (Baltimore, Md.) 1993;18(2):246-52.
1993: Dimitrios Karussis; U Vourka-Karussis; D Lehmann; Haim Ovadia; Rachel Mizrachi-Koll; Avraham Ben-Nun; Oded Abramsky; Shimon Slavin
Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.
The Journal of clinical investigation 1993;92(2):765-72.
1993: Dimitrios Karussis; D Lehmann; Shimon Slavin; U Vourka-Karussis; Rachel Mizrachi-Koll; Haim Ovadia; T Kalland; Oded Abramsky
Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).
Proceedings of the National Academy of Sciences of the United States of America 1993;90(14):6400-4.
1993: Shimon Slavin
Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT.
Bone marrow transplantation 1993;12(1):85-8.
1993: Joseph Kapelushnik; Arnon Nagler; Reuven Or; Elizabeth Naparstek; G Cividalli; Memet Aker; J Mehta; M Mumcuoglu; Shimon Slavin
Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging.
Transplantation proceedings 1993;25(3):2375-6.
1993: Yaron Ilan; Arnon Nagler; R Adler; R Tur-Kaspa; Shimon Slavin; Daniel Shouval
Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor.
Gastroenterology 1993;104(6):1818-21.
1993: Shoshana Morecki; Arnon Nagler; Y Puyesky; C Nabet; Reba Condiotti; M Pick; S Gan; Shimon Slavin
Effect of various cytokine combinations on induction of non-MHC-restricted cytotoxicity.
Lymphokine and cytokine research 1993;12(3):159-65.
1993: Dan Engelhard; Elizabeth Naparstek; Reuven Or; Arnon Nagler; J Jacobs; M B Shahar; Izhar Hardan; H Baciu; D Raveh; Shimon Slavin
Ganciclovir for the treatment of disseminated CMV disease without pneumonia in allogeneic T-lymphocyte depleted bone marrow transplantation.
Leukemia & lymphoma 1993;10(1-2):143-6.
1993: Shimon Slavin; Dimitrios Karussis; Lola Weiss; U Vourka-Karussis; Oded Abramsky
Immunohematopoietic reconstitution by allogeneic and autologous bone marrow grafts as a means for induction of specific unresponsiveness to donor-specific allografts and modified self in autoimmune disorders.
Transplantation proceedings 1993;25(1 Pt 2):1274-5.
1993: Arnon Nagler; M Mumcuoglu; Elizabeth Naparstek; Reuven Or; S Gan; Shimon Slavin
Normal hematopoietic reconstitution following ASTA-Z 7557-purged grafts in the absence of in vitro CFU-GM colony growth.
Leukemia research 1993;17(1):61-7.
1993: Elizabeth Naparstek; M Ohana; J S Greenberger; Shimon Slavin
Continuous intravenous administration of rmGM-CSF enhances immune as well as hematopoietic reconstitution following syngeneic bone marrow transplantation in mice.
Experimental hematology 1993;21(1):131-7.
1993: Shimon Slavin; Lola Weiss; Aliza Ackerstein; U Vourka-Karussis; Shoshana Morecki; Reuven Or; Arnon Nagler; Joseph Kapelushnik; M Delukina; P Drakos
Prevention and treatment of relapse by bone marrow transplantation.
Bone marrow transplantation 1993;12 Suppl 3():S54-6.
1992: J Stark; Lola Weiss; Shimon Slavin
Radiosensitivity and responsiveness to recombinant interleukin-2 of effector cells of graft vs. host disease and mixed lymphocyte reaction in mice.
Israel journal of medical sciences 1992;28(11):767-72.
1992: Shimon Slavin; Reuven Or; Y Kapelushnik; P Drakos; Aliza Ackerstein; U Vourka-Karussis; Lola Weiss; Arnon Nagler
Immunotherapy of minimal residual disease in conjunction with autologous and allogeneic bone marrow transplantation (BMT).
Leukemia 1992;6 Suppl 4():164-6.
1992: Reuven Or; J Mehta; Elizabeth Naparstek; E Okon; G Cividalli; Shimon Slavin
Successful T cell-depleted allogeneic bone marrow transplantation in a child with recurrent multiple extramedullary plasmacytomas.
Bone marrow transplantation 1992;10(4):381-2.
1992: Simcha Samuel; Arnon Nagler; Reuven Or; Shimon Slavin
Effects of interleukin 2 on engraftment following autologous bone marrow transplantation (ABMT) in dogs.
Leukemia research 1992;16(10):967-72.
1992: Elizabeth Naparstek; Y Hardan; M Ben-Shahar; Arnon Nagler; Reuven Or; M Mumcuoglu; Lola Weiss; Simcha Samuel; Shimon Slavin
Enhanced marrow recovery by short preincubation of marrow allografts with human recombinant interleukin-3 and granulocyte-macrophage colony-stimulating factor.
Blood 1992;80(7):1673-8.
1992: P E Drakos; Arnon Nagler; Reuven Or; S Gillis; Shimon Slavin; Amiram Eldor
Low molecular weight heparin for Hickman catheter--induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation.
Cancer 1992;70(7):1895-8.
1992: Dimitrios Karussis; Shimon Slavin; Avraham Ben-Nun; Haim Ovadia; U Vourka-Karussis; D Lehmann; R Mizrachi-Kol; Oded Abramsky
Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation.
Journal of neuroimmunology 1992;39(3):201-10.
1992: A Bieder; Lola Weiss; Shimon Slavin
The role of recombinant cytokines and other immunomodulators on engraftment following allogeneic bone marrow transplantation in mice.
Bone marrow transplantation 1992;9(6):421-6.
1992: Dimitrios Karussis; Shimon Slavin; D Lehmann; Rachel Mizrachi-Koll; Oded Abramsky; Avraham Ben-Nun
Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation.
Journal of immunology (Baltimore, Md. : 1950) 1992;148(6):1693-8.
1992: Raphael Breuer; Z Tochner; M W Conner; A Nimrod; M Gorecki; Reuven Or; Shimon Slavin
Superoxide dismutase inhibits radiation-induced lung injury in hamsters.
Lung 1992;170(1):19-29.
1992: Shimon Slavin; Aliza Ackerstein; Lola Weiss; Arnon Nagler; Reuven Or; Elizabeth Naparstek
Immunotherapy of minimal residual disease by immunocompetent lymphocytes and their activation by cytokines.
Cancer investigation 1992;10(3):221-7.
1992: Arnon Nagler; L Pavel; Elizabeth Naparstek; Michael Muggia-Sullam; Shimon Slavin
Typhlitis occurring in autologous bone marrow transplantation.
Bone marrow transplantation 1992;9(1):63-4.
1992: Shimon Slavin; Elizabeth Naparstek; M Ziegler; A Lewin
Clinical application of intrauterine bone marrow transplantation for treatment of genetic diseases--feasibility studies.
Bone marrow transplantation 1992;9 Suppl 1():189-90.
1992: Shoshana Morecki; S Revel-Vilk; C Nabet; M Pick; Aliza Ackerstein; Arnon Nagler; Elizabeth Naparstek; M Ben Shahar; Shimon Slavin
Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-alpha 2a and interleukin-2.
Cancer immunology, immunotherapy : CII 1992;35(6):401-11.
1991: Dan Engelhard; R Handsher; Elizabeth Naparstek; Izhar Hardan; N Strauss; Memet Aker; Reuven Or; H Baciu; Shimon Slavin
Immune response to polio vaccination in bone marrow transplant recipients.
Bone marrow transplantation 1991;8(4):295-300.
1991: Aliza Ackerstein; Eli Kedar; Shimon Slavin
Use of recombinant human interleukin-2 in conjunction with syngeneic bone marrow transplantation in mice as a model for control of minimal residual disease in malignant hematologic disorders.
Blood 1991;78(5):1212-5.
1991: Shimon Slavin; Aliza Ackerstein; U Vourka-Karussis; Arnon Nagler; Reuven Or; E Naparstek; Lola Weiss
Control of relapse due to minimal residual disease (MRD) by cell-mediated cytokine-activated immunotherapy in conjunction with bone marrow transplantation.
Baillière's clinical haematology 1991;4(3):715-25.
1991: Reuven Or; Elizabeth Naparstek; N Mani; Shimon Slavin
Treatment of pure red-cell aplasia following major ABO-mismatched T-cell-depleted bone marrow transplantation. Two case reports with successful response to plasmapheresis.
Transplant international : official journal of the European Society for Organ Transplantation 1991;4(2):99-102.
1991: S Gomez; Arnon Nagler; Elizabeth Naparstek; Shimon Slavin
Transient elevation of serum lactic dehydrogenase following autologous bone marrow transplantation.
Bone marrow transplantation 1991;7(6):487-8.
1991: Shoshana Morecki; C Nabet; Aliza Ackerstein; M Schlesinger; Shimon Slavin
The effect of in vitro T lymphocyte depletion on generation of IL2-activated cytotoxic cells.
Bone marrow transplantation 1991;7(4):269-73.
1991: M Mumcuoglu; Zichria Zakay-Rones; Lola Weiss; Shimon Slavin
The effect of total or partial T lymphocyte depletion on susceptibility to influenza virus infection and development of antiviral immunity in lethally irradiated mice reconstituted with immune syngeneic bone marrow grafts.
Bone marrow transplantation 1991;7(3):217-20.
1991: Shimon Slavin; Aliza Ackerstein; Eli Kedar; Shoshana Reich; S Gomez; Elizabeth Naparstek; Arnon Nagler; Reuven Or; Lola Weiss
Induction of cell-mediated IL-2-activated antitumor responses in conjunction with autologous and allogeneic bone marrow transplantation.
Transplantation proceedings 1991;23(1 Pt 1):802-3.
1991: M Gorecki; Y Beck; J R Hartman; M Fischer; L Weiss; Z Tochner; Shimon Slavin; A Nimrod
Recombinant human superoxide dismutases: production and potential therapeutical uses.
Free radical research communications 1991;12-13 Pt 1():401-10.
1990: Ahmed Eid; Shoshana Morecki; Shimon Slavin
The use of parabiosis for investigating the mechanism of transplantation tolerance in bone marrow chimeras induced by total lymphoid irradiation.
Transplant international : official journal of the European Society for Organ Transplantation 1990;3(3):141-5.
1990: Lola Weiss; Shoshana Reich; Shimon Slavin
Effect of cyclosporine A and methylprednisolone on the graft-versus-leukemia effects across major histocompatibility barriers in mice following allogeneic bone marrow transplantation.
Bone marrow transplantation 1990;6(4):229-33.
1990: Shimon Slavin; Aliza Ackerstein; Elizabeth Naparstek; Reuven Or; Lola Weiss
The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD?
Bone marrow transplantation 1990;6(3):155-61.
1990: Shimon Slavin; Aliza Ackerstein; Eli Kedar; Lola Weiss
IL-2 activated cell-mediated immunotherapy: control of minimal residual disease in malignant disorders by allogeneic lymphocytes and IL-2.
Bone marrow transplantation 1990;6 Suppl 1():86-90.
1990: M Mumcuoglu; Elizabeth Naparstek; Shimon Slavin
The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow.
Bone marrow transplantation 1990;5(3):153-8.
1990: Lola Weiss; M Weigensberg; Shoshana Morecki; S Bar; S Cobbold; H Waldmann; Shimon Slavin
Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia.
Cancer immunology, immunotherapy : CII 1990;31(4):236-42.
1990: Shimon Slavin; A Eckerstein; Izhar Hardan; M Ben Shahar; Reuven Or; Elizabeth Naparstek; Lola Weiss
Toward improvement of therapeutic strategies in leukemia by amplification of the immune responses against leukemia.
Haematology and blood transfusion 1990;33():36-40.
1990: A Eckerstein; Shimon Slavin; Lola Weiss; Elizabeth Naparstek
Immunotherapy in conjunction with autologous bone marrow transplantation.
Bone marrow transplantation 1990;5 Suppl 1():38.
1990: M Mumcuoglu; M Favrot; Shimon Slavin
Lectin-binding properties of Burkitt's lymphoma cell lines: application to bone marrow purging.
Experimental hematology 1990;18(1):55-60.
1990: Z Weshler; Raphael Breuer; Reuven Or; Elizabeth Naparstek; M R Pfeffer; E Lowental; Shimon Slavin
Interstitial pneumonitis after total body irradiation: effect of partial lung shielding.
British journal of haematology 1990;74(1):61-4.
1989: Shimon Slavin; M Mumcuoglu; A Landesberg-Weisz; Eli Kedar
The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
Bone marrow transplantation 1989;4(5):459-64.
1989: Shoshana Morecki; Shimon Slavin; S A Ben-Sasson
Selective abrogation of alloreactivity via priming in the presence of aphidicolin, a specific inhibitor of DNA polymerase.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(3):838-43.
1989: M Mumcuoglu; Lola Weiss; J Spivak; Shimon Slavin
Differential killing of murine B-cell leukemia (BCL1) by photosensitization with merocyanine 540: implications for autologous bone marrow transplantation.
Bone marrow transplantation 1989;4(2):143-6.
1989: Shimon Slavin; Elizabeth Naparstek; Memet Aker; G Cividalli; Dan Engelhard; Y Hardan; R Bromiker; Chaim Brautbar; Z Weshler; Reuven Or
The use of total lymphoid irradiation (TLI) for prevention of rejection of T-lymphocyte depleted bone marrow allografts in non-malignant hematological disorders.
Transplantation proceedings 1989;21(1 Pt 3):3053-4.
1988: Z Tochner; Shimon Slavin
Immune modulation by ionized irradiation.
Current opinion in immunology 1988;1(2):261-8.
1988: Raphael Breuer; Reuven Or; G Lijovetzky; Elizabeth Naparstek; Dan Engelhard; JS Lafair; Z Weshler; Shimon Slavin
Interstitial pneumonitis in T cell-depleted bone marrow transplantation.
Bone marrow transplantation 1988;3(6):625-30.
1988: Shoshana Morecki; Shimon Slavin
Combination of magnetic and chemocytotoxic cancer cell depletion for autologous bone marrow transplantation.
Israel journal of medical sciences 1988;24(9-10):488-93.
1988: Shoshana Morecki; S Margel; Shimon Slavin
Removal of breast cancer cells by soybean agglutinin in an experimental model for purging human marrow.
Cancer research 1988;48(16):4573-7.
1988: Ahmed Eid; Shoshana Morecki; Shimon Slavin
Induction of transplantation tolerance by intraportal injection of allogeneic bone marrow cells. Possible implications for intrauterine bone marrow transplantation across major histocompatibility barriers.
Transplant international : official journal of the European Society for Organ Transplantation 1988;1(2):109-12.
1988: Eli Kedar; B Z Tsuberi; A Landesberg; M Anafi; Benny Leshem; S Gillis; D L Urdal; Shimon Slavin
In vitro and in vivo cytokine-induced facilitation of immunohematopoietic reconstitution in mice undergoing bone marrow transplantation.
Bone marrow transplantation 1988;3(4):297-314.
1988: Shimon Slavin
Use of total lymphoid irradiation (TLI) for the treatment of autoimmune disorders.
Israel journal of medical sciences 1988;24(7):375-8.
1988: A B Yehuda; Reuven Or; Elizabeth Naparstek; Shimon Slavin; A Polliack
T-cell depleted bone marrow transplantation for plasma cell myeloma. Report of a case and review of the results of BMT for myeloma.
Blut 1988;56(5):229-31.
1988: Lola Weiss; E Bullorsky; Y J Ashkenazi; Shimon Slavin
Optimal time interval between myeloablative whole body irradiation and reconstitution with syngeneic bone marrow graft.
Bone marrow transplantation 1988;3(3):207-10.
1988: Dan Engelhard; Avraham Morag; Reuven Or; Elizabeth Naparstek; G Cividalli; R Ruchlemer; Memet Aker; S Maayan; Shimon Slavin
Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
Israel journal of medical sciences 1988;24(3):145-50.
1988: Eli Kedar; Reuven Or; Elizabeth Naparstek; E Zeira; Shimon Slavin
Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT).
Bone marrow transplantation 1988;3(2):129-40.
1988: Shimon Slavin; A Eckerstein; Lola Weiss
Adoptive immunotherapy in conjunction with bone marrow transplantation--amplification of natural host defence mechanisms against cancer by recombinant IL-2.
Natural immunity and cell growth regulation 1988;7(3):180-4.
1987: Yair Gazitt; Reuven Or; M Mumcuoglu; Shimon Slavin
Monoclonal rat anti-human lymphocyte antibody Campath-1 binds to T and B lymphocytes but effectively lyses only T cells.
Bone marrow transplantation 1987;2(4):427-33.
1987: M Mumcuoglu; Zichria Zakay-Rones; G Parag; Lola Weiss; Shimon Slavin
The effect of T lymphocyte depletion on susceptibility to influenza virus infection and development of anti-viral immunity in lethally irradiated mice reconstituted with syngeneic bone marrow grafts.
Bone marrow transplantation 1987;2(4):403-12.
1987: Benny Leshem; Z Lebendiker; Lola Weiss; Shimon Slavin; Eli Kedar
Suppressor T cells in allogeneic bone marrow chimeras.
Bone marrow transplantation 1987;2(2):123-32.
1987: Benny Leshem; B Z Tsuberi; Z Lebendiker; M Anafi-Ayalon; M Shalit; Lola Weiss; Shimon Slavin; Eli Kedar
Bone marrow transplantation with T-cell-depleted grafts. II. Reconstitution of immunohemopoietic functions in lethally irradiated mice transplanted with unseparated or T-cell-depleted bone marrow grafts disparate at minor histocompatibility antigens.
Transplantation 1987;43(6):814-7.
1987: Shoshana Morecki; F Pavlotzky; S Margel; Shimon Slavin
Purging breast cancer cells in preparation for autologous bone marrow transplantation.
Bone marrow transplantation 1987;1(4):357-63.
1987: B Tsuberi; Shimon Slavin; Eli Kedar; Benny Leshem
Transfer of B memory cells to a T-dependent antigen in murine bone marrow transplantation.
Transplantation proceedings 1987;19(1 Pt 3):2747-9.
1987: Shimon Slavin; Reuven Or; Elizabeth Naparstek; Lola Weiss; M Mumcuoglu; Z Weshler; H Brautbar; G Cividalli; M Glikson; G Hale
Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
Transplantation proceedings 1987;19(1 Pt 3):2614-5.
1986: Shimon Slavin; Shoshana Morecki; M Weigensberg; S Bar; Lola Weiss
Functional clonal deletion versus suppressor cell-induced transplantation tolerance in chimeras prepared with a short course of total-lymphoid irradiation.
Transplantation 1986;41(6):680-7.
1986: Shimon Slavin; Eliezer A Rachmilewitz
Bone marrow transplantation in thalassaemia.
Bone marrow transplantation 1986;1(1):11-5.
1985: Shoshana Morecki; B Leshem; M Weigensberg; S Bar; Shimon Slavin
Functional clonal deletion versus active suppression in transplantation tolerance induced by total-lymphoid irradiation.
Transplantation 1985;40(2):201-10.
1985: Shoshana Morecki; M Weigensberg; Shimon Slavin
Lectin separation of nonlymphoid suppressor cells induced by total lymphoid irradiation.
European journal of immunology 1985;15(2):138-48.
1985: Shimon Slavin; R Or; Z Weshler; Z Fuks; Shoshana Morecki; M Weigensberg; S Bar; Lola Weiss
The use of total lymphoid irradiation for allogeneic bone marrow transplantation in animals and man.
Survey of immunologic research 1985;4(3):238-52.
1985: Shimon Slavin; M Weigensberg; S Bar; Lola Weiss; Shoshana Morecki
The role of suppressor T lymphocytes in the maintenance of tolerance to alloantigens in bone marrow chimeras prepared with total lymphoid irradiation (TLI).
Advances in experimental medicine and biology 1985;186():503-9.
1984: M Weigensberg; Shoshana Morecki; Lola Weiss; Z Fuks; Shimon Slavin
Suppression of cell-mediated immune responses after total lymphoid irradiation (TLI). I. Characterization of suppressor cells of the mixed lymphocyte reaction.
Journal of immunology (Baltimore, Md. : 1950) 1984;132(2):971-8.
1984: Shoshana Morecki; Shimon Slavin; Lola Weiss; M Weigensberg; A Friedman; M Kotler
Demonstration and characterization of virus released by murine B cell leukemia cells (BCL1).
Leukemia research 1984;8(5):821-32.